Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ:AMEX Investor Relations:
ir.titanpharm.com
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum $1.00 bid price requirement and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. As such, the listing matter has been closed. About Titan Pharmaceuticals Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with utilizing ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes. In December 2021
Show less
Read more
Impact Snapshot
Event Time:
TTNP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTNP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTNP alerts
High impacting Titan Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
TTNP
News
- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
TTNP
Sec Filings
- 4/26/24 - Form RW
- 4/5/24 - Form SC
- 4/5/24 - Form 3
- TTNP's page on the SEC website